Abstract
About 30% of the drugs sold worldwide are based on natural products. Though recombinant proteins and peptides account for an increasing market volume, the superiority of low-molecular-mass compounds in human disease therapy remains undisputed, due mainly to more favorable compliance and bioavailability properties. In the past, new therapeutic approaches have often evolved from research involving natural products. Numerous examples from medicine impressively demonstrate the innovative potential of natural compounds and their impact on progress in drug discovery and development. However, natural products are currently undergoing a phase of reduced attention because of the enormous effort which is necessary to isolate the active principles and to elucidate their chemical structures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Attaway DH, Zaborsky OR (eds) (1993) Pharmaceutical and bioactive natural products. Plenum, New York (Marine biotechnology, vol 1)
Bach G, Breiding-Mack S, Grabley S, Hammann P, Hütter K, Thiericke R, Uhr H, Wink J, Zeeck A (1993) Liebigs Ann Chem 241
Becker EW (1994) Microalgae: biotechnology and microbiology. Cambridge University Press, Cambridge
Beese K (1996) Pharmaceutical bioprospecting and synthetic molecular diversity. Draft discussion paper, 15 May
Berteis S, Frormann S, Jas G, Bindseil KU (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p72
Bindseil KU, God R, Gumm H, Mellor F (1997) GIT Spezial Chromatogr 1:19
Blum S, Fiedler HP, Groth I, Kempter C, Stephan H, Nicholson G, Metzger J, Jung, G (1995) J Antibiot 48:619
Blum S, Groth I, Rohr J, Fiedler H-P (1996) J Basic Microbiol 36:19
Burkhardt K, Fiedler HP, Grabley S, Thiericke R, Zeeck A (1996) J Antibiot 49:432
Christner C (1998) PhD thesis, Halle-Wittenberg
Christner C, Küllertz G, Fischer G, Zerlin M, Grabley S, Thiericke R, Taddei A, Zeeck A (1998) J Antibiot 51:368
Christner C, Wyrwa R, Marsch S, Küllertz G, Thiericke R, Grabley S, Schumann D, Fischer G (1999) J Med Chem 42:3615
de Vries DJ, Beart PM (1995) TIBS 16:275
Dräger G, Kirschning A, Thiericke R, Zerlin M (1996) Nat Prod Rep 13:365
Drautz H, Reuschenbach P, Zähner H, Rohr J, Zeeck A (1985) J Antibiot 38:1292
Drautz H, Zähner H, Rohr J, Zeeck A (1986) J Antibiot 39:1657
Ebert G (1999) PhD thesis. Jena and Berlin
Ebert G, Thiericke R, Grabley S (1997) Patent application. FN 19753900.9
Fiedler H-P (1984) J Chromatogr 316:487
Fiedler H-P, Rohr J, Zeeck A (1986) J Antibiot 39:856
Fiedler HP, Kulik A, Schütz T, Volkmann C, Zeeck A (1994) J Antibiot 47:1116
Fischer G (1994) Angew Chem Int Ed 33:1415
Fischer G (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 257
Fischer G, Tradier T, Zarnt T (1998) FEBS Lett 426:17
Fuchser J, Grabley S, Noltemeyer M, Philipps S, Thiericke R, Zeeck A (1994) Liebigs Ann Chem 831
Göhrt A, Zeeck A, Hütter K, Kirsch R, Kluge H, Thiericke R (1992) J Antibiot 45:66
Göhrt A, Grabley S, Thiericke R, Zeeck A (1996) Liebigs Ann Chem 627
Goodfellow M, Williams ST, Mordarski (eds) (1988) Actinomycetes in biotechnology. Academic, London
Grabley S, Thiericke R (1999) Adv Biochem Engin/Biotechnol 64:101
Grabley S, Granzer E, Hütter K, Ludwig D, Mayer M, Thiericke R, Till G, Wink J (1992a) J Antibiot 45:56
Grabley S, Hammann P, Hütter K, Kirsch R, Kluge H, Thiericke R, Mayer M, Zeeck A (1992b) J Antibiot 45:1176
Grabley S, Kretzschmar G, Mayer M, Philipps S, Thiericke R, Wink J, Zeeck A (1993) Liebigs Ann Chem 573
Grabley S, Thiericke R, Zeeck A (1994a) Antibiotika und andere mikrobielle Wirkstoffe. In: Präve P, Faust U, Sittig W, Sukatsch DA (eds) Handbuch der Biotechnologie, 4th edn. Oldenbourgverlag, Munich, p 663
Grabley S, Thiericke R, Wink J, Henne P, Philipps S, Wessels P, Zeeck A (1994b) J Nat Prod 57:541
Grabley S, Thiericke R, Zerlin M, Göhrt A, Philipps S, Zeeck A (1996) J Antibiot 49:593
Grabley S, Thiericke R (eds) (1999a) Drug discovery from nature. Springer, Berlin Heidelberg New York
Grabley S, Thiericke R, Zeeck (1999b) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 124
Gräfe U (1992) Biochemie der Antibiotika. Spektrum, Heidelberg
Grote R, Zeeck A, Drautz H, Zähner H (1988a) J Antibiot 41:1178
Grote R, Zeeck A, Beale Jr. JM (1988b) J Antibiot 41:1186
Gu Z-M, Zhou D, Wu J, Shi G, Zeng L, McLaughlin JL (1997) J Nat Prod 60:242
Gusovsky F, Daly JW (1990) Biochem Pharmacol 39:1633
Hamilton GS, Steiner JP (1997) Curr Pharmacol Design 3:405
Henkel T, Zeeck A (1991) Liebigs Ann Chem 367
Henkel T, Breiding-Mack S, Zeeck A, Grabley S, Hammann PE, Hütter K, Till G, Thiericke R, Wink J (1991) Liebigs Ann Chem 575
Henkel T, Brunne RM, Müller H, Reichel F (1999) Angew Chem 111:688
Henne P, Thiericke R, Grabley S, Hütter K, Wink J, Jurkiewicz E, Zeeck A (1993) Liebigs Ann Chem 565
Henne P, Grabley S, Thiericke R, Zeeck A (1997) Liebigs Ann Recueil 937
Hennig L, Christner C, Kipping M, Schelbert B, Rücknagel KP, Grabley S, Küllertz G, Fischer G (1998) Biochemistry 37:5953
Hoff H, Drautz H, Fiedler H-P, Zähner H, Schultz JE, Keller-Schierlein W, Philipps S, Ritzau M, Zeeck A (1992) J Antibiot 45:1096
Hostettmann K, Potterat O, Wolfender J-L (1997) Pharm Ind 59:339
Hutchinson CR (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 233
Jensen PR, Fenical W (1996) J Ind Microbiol 17:346
Kay JE (1996) Biochem J 314:361
Keinan E, Sinha A, Yazbak A, Sinha Santosh C, Sinha Subhash C (1997) Pure Appl Chem 69:423
Koch C, Neumann T, Thiericke R, Grabley S (1997a) Nachr Chem Tech Lab 45:16
Koch C, Neumann T, Thiericke R, Grabley S (1997b) Blospektrum 3:43
Koch C, Neumann T, Thiericke R, Grabley S (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p51
König GM, Wright AD (1996) Planta Med 62:193
König GM, Wright AD (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 180
Kuhn W, Fiedler H-P (eds) (1995) Sekundärmetabolismus bei Mikroorganismen, Beiträge zur Forschung (engl). Attempto, Tübingen
Lost JL, Kominek LA, Hyatt GS, Wang HY (1984) Drugs Pharm Sei 22:531
Luckas B (1996) GIT 4:355
Marks AR (1996) Physiol Rev 76:631
Mayer M, Thiericke R (1993a) J Antibiot 46:1372
Mayer M, Thiericke R (1993b) J Chem Soc Perkin Trans 1:2525
Morino T, Nishimoto M, Masuda A, Fujita S, Nishikiori T, Saito S (1995) J Antibiot 48:1509
Omura S (ed) (1992) The search for bioactive compounds from microorganisms. Springer, Berlin New York New York
Omura S, Tanaka Y, Kanaya I, Shinose M, Takahashi Y (1990) J Antibiot 43:1034
Paululat T, Tang YQ, Grabley S, Thiericke R (1999) Chimica Oggi/Chemistry Today 52 May/June
Petrini O, Sieber TN, Toti L, Viret O (1992) Natural Toxins 1:185
Pfefferle C, Kempter C, Metzger J, Fiedler HP (1996) J Antibiot 49:826
Reggelin M, Brenig V, Welcker R (1998) Tetrahedron Lett 39:4801
Reichenbach H, Höfle G (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 149
Ritzau M, Philipps S, Zeeck A, Hoff H, Zähner H (1993a) J Antibiot 46:1625
Ritzau M, Keller M, Wessels P, Stetter KO, Zeeck A (1993b) Liebigs Ann Chem871
Rodriguez S, Wolfender J-L, Hostettmann K, Odontuya G, Purev O (1996) Helv Chim Acta 79:363
Rohr J (1995) Angew Chem Int Ed Eng 34:881
Rohr J, Thiericke R (1992) Nat Prod Rep 9:103
Rohr J, Zeeck A (1987) J Antibiot 40:459
Sattler I, Grabley S, Thiericke R (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 191
Schmid I, Sattler I, Grabley S, Thiericke R (1999) J Biomol Screening 4:15
Schneider A, Späth J, Breiding-Mack S, Zeeck A, Grabley S, Thiericke R (1996) J Antibiot 49:438
Schönewolf M, Rohr J (1991) Angew Chem 103:211
Schönewolf M, Grabley S, Hütter K, Machinek R, Wink J, Zeeck A, Rohr J (1991) Liebigs Ann Chem 77
Shimizu Y (1993) In: Attaway DH, Zaborsky OR (eds) Marine biotechnology, vol 1. Plenum, New York, p 391
Strobel GA, Hess WM, Ford E, Sidhu RS, Yang X (1996) J Ind Microbiol 17:417
Tanaka Y, Kanaya I, Shiomi KM, Tanaka H, Omura S (1993a) J Antibiot 46:1214
Tanaka Y, Kanaya I, Takahashi Y, Shinose M, Tanaka H, Omura S (1993b) J Antibiot 46:1208
Thiericke R, Zerlin M (1996) Nat Prod Lett 8:163
Thiericke R, Grabley S, Geschwill K (1999) In: Grabley S, Thiericke R (eds) Drug discovery from nature. Springer, Berlin Heidelberg New York, p 56
Vandamme EJ (ed) (1984) Biotechnology of industrial antibiotics, drugs and pharmaceutical sciences, vol 22. Dekker, New York
Volkmann C, Hartjen U, Zeeck A, Fiedler HP (1995) J Antibiot 48:522
Vreven F (1997) Labo, July, p 48
Yarbrough GG, Taylor DP, Rowlands RT, Crawford MS, Lasure LL (1993) J Antibiot 46:535
Yasumoto T, Bagnis R, Venoux JP (1976) Bull Jpn Soc Sei Fish 42:359
Zerlin M, Thiericke R (1994) J Org Chem 59:6986
Zerlin M, Christner C, Thiericke R, Hinze C, Grabley S, Kiillertz G, Fischer G, Zeeck A (1996) BRD-patent application DE 196 03 510
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Grabley, S., Thiericke, R., Sattler, I. (2000). Tools for Drug Discovery: Natural Product-based Libraries. In: Mulzer, J., Bohlmann, R. (eds) The Role of Natural Products in Drug Discovery. Ernst Schering Research Foundation Workshop, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04042-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-04042-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04044-7
Online ISBN: 978-3-662-04042-3
eBook Packages: Springer Book Archive